Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)

NCT00266812 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

INDUSTRY

Sponsor class

Stopped Patient target could not be reached within the planned timeframe.

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Temozolomide and radiotherapy
PROCEDURE: Whole brain radiotherapy

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]